trial summary · NCT07292298
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
Trial record from the TrialBase DB dataset, status RECRUITING, condition Rectal Adenocarcinoma, sponsored by University of Colorado, Denver. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Rectal cancer patients who do not achieve a complete response to standard of care chemotherapy and radiation often require surgical resection as part of curative intent therapy. This study will evaluate whether additional "focal" radiation delivered internally (rectal brachytherapy) can provide complete responses and thus spare the requirement for surgery. The main questions are whether: 1) rectal brachytherapy is safe in this clinical treatment paradigm and if 2) rectal brachytherapy improves organ preservation (no need for surgery). The trial involves an additional MRI pelvis and sigmoidoscopy with marker placement to define high-risk residual disease for radiation planning. Subsequently, 3 outpatient brachytherapy treatments are given on a weekly basis. If a patient achieves a complete response to brachytherapy, standard of care non-operative surveillance visits are conducted with study visits aligned during the first two years following brachytherapy.
Source record: https://clinicaltrials.gov/study/NCT07292298
Facts
| registry id | NCT07292298 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE2 |
| study type | INTERVENTIONAL |
| lead condition | Rectal Adenocarcinoma |
| sponsor | University of Colorado, Denver |
| sponsor class | OTHER |
| enrollment | 44 |
| start date | 2026-11 |
| primary completion | 2030-11 |
| completion | 2031-11 |
| results posted | not reported |
Conditions
- Rectal Adenocarcinoma
- Rectal Cancer
Interventions
- High Rare Dose Rectal Brachytherapy Boost
Countries
- United States
Intervention types: RADIATION
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.